Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hyaluronic Acid Dressing (Qanxin Biotech) is a topical medical device developed by Hangzhou Quanxin Biotech Co., Ltd. (Qanxin Biotech). It is a hyaluronic acid-based dressing designed for wound care, skin repair, and general skincare. The product functions by creating a moist environment on the skin or wound surface, which facilitates the natural healing process and maintains high levels of hydration. As a medical device, its primary mode of action is physical and mechanical—providing a protective barrier and moisture retention—rather than pharmacological, metabolic, or immunological. It is typically used for the management of non-infected wounds, post-operative skin recovery, and inflammatory skin conditions like dermatitis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Hyaluronic Acid Dressing (Qanxin Biotech).